ACECLOFENAC LOADED FILM FORMING GELS: IN VIVO STUDY

Q4 Pharmacology, Toxicology and Pharmaceutics
H. Bajaj, M. Yadav, Seema B. Chauhan, Anjali Sharma, Navin C. Pant, Vinod Singh, Mamta F. Singh
{"title":"ACECLOFENAC LOADED FILM FORMING GELS: IN VIVO STUDY","authors":"H. Bajaj, M. Yadav, Seema B. Chauhan, Anjali Sharma, Navin C. Pant, Vinod Singh, Mamta F. Singh","doi":"10.53879/id.60.06.13865","DOIUrl":null,"url":null,"abstract":"For arthritis, there is need of development of a drug delivery system which permits less frequent dosing by maintaining a close contact with the skin for prolonged time period, thereby improving the patient compliance, especially among elderly. Till date, film forming gels of aceclofenac for arthritis are not available in the market. It is a novel approach which can be used as an alternative to conventional topical and transdermal formulations to treat arthritis. Therefore, HPMC and Eudragit RL 100 based film forming gels of aceclofenac were prepared. On the basis of in vitro potential, the formulation was further selected and evaluated for their acute skin irritation studies and in vivo anti-arthritic activity using primary skin irritation (draize) test and Freund’s Complete Adjuvant (FCA) induced arthritis method. The tested formulations were devoid of any irritation potential and no edema formation was observed in any cases Irritation score (primary skin irritation index) for all the formulations was found to be zero, which indicates its safety and acceptability for transdermal administration. The in vivo study revealed that there was significant reduction in inflamed paw volume compared to the marketed formulation. The developed film forming gels could be a potential drug delivery platform for the management of arthritis.","PeriodicalId":13409,"journal":{"name":"INDIAN DRUGS","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"INDIAN DRUGS","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53879/id.60.06.13865","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

For arthritis, there is need of development of a drug delivery system which permits less frequent dosing by maintaining a close contact with the skin for prolonged time period, thereby improving the patient compliance, especially among elderly. Till date, film forming gels of aceclofenac for arthritis are not available in the market. It is a novel approach which can be used as an alternative to conventional topical and transdermal formulations to treat arthritis. Therefore, HPMC and Eudragit RL 100 based film forming gels of aceclofenac were prepared. On the basis of in vitro potential, the formulation was further selected and evaluated for their acute skin irritation studies and in vivo anti-arthritic activity using primary skin irritation (draize) test and Freund’s Complete Adjuvant (FCA) induced arthritis method. The tested formulations were devoid of any irritation potential and no edema formation was observed in any cases Irritation score (primary skin irritation index) for all the formulations was found to be zero, which indicates its safety and acceptability for transdermal administration. The in vivo study revealed that there was significant reduction in inflamed paw volume compared to the marketed formulation. The developed film forming gels could be a potential drug delivery platform for the management of arthritis.
醋氯芬酸载膜凝胶的体内研究
对于关节炎,需要开发一种药物递送系统,该系统通过长时间与皮肤保持密切接触来减少给药频率,从而提高患者的依从性,尤其是在老年人中。到目前为止,市场上还没有针对关节炎的醋氯芬酸成膜凝胶。这是一种新的方法,可以作为传统的局部和透皮制剂的替代品来治疗关节炎。因此,制备了基于HPMC和Eudragit RL 100的醋氯芬酸成膜凝胶。在体外潜力的基础上,使用原发性皮肤刺激性(draize)试验和弗氏完全佐剂(FCA)诱导的关节炎方法,进一步选择并评估了该制剂的急性皮肤刺激性研究和体内抗关节炎活性。测试的制剂没有任何刺激潜力,在任何情况下都没有观察到水肿形成。所有制剂的刺激评分(主要皮肤刺激指数)均为零,这表明其透皮给药的安全性和可接受性。体内研究表明,与市场上的配方相比,发炎的爪子体积显著减少。所开发的成膜凝胶可能是治疗关节炎的潜在药物递送平台。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
INDIAN DRUGS
INDIAN DRUGS Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science
CiteScore
0.30
自引率
0.00%
发文量
98
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信